| Schmidt Futures | Futures Forum on Learning: Tools Competition | 9/18/2020 |
| NIH, NIA, NCI, RM, NCATS, NHLBI, NIDCR, NIDA, NHGRI | Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed) | 9/18/2020 |
| NIH, NIAAA, NIAMS, NICHD, NIBIB, NIMHD, NLM, NCATS, NHLBI, NIDCR | Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed) | 9/18/2020 |
| NIH, NIAAA, NIA, NIAMS, NICHD, NIBIB, NIMHD, NLM, NCATS, NHLBI, NIDCR | Emergency Awards RADx-RAD: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (U18 Clinical Trial Not Allowed) | 9/18/2020 |
| NIH, NIAAA, NIA, NCCIH, NIDCD, NIDDK, NIEHS, NIGMS, NICHD, NIMHD, NLM, NINR, NCATS, OBSSR, NHLBI, NIDCR, NIDA | Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed) | 9/18/2020 |
| NIH, NIOSH | NIOSH Centers of Excellence for Total Worker Health® (U19) - LIMITED | 9/25/2020;
Various |
| CEPI | Accelerating vaccine development and global manufacturing capacity to stop the COVID-19 pandemic | 9/28/2020 |
| FDA | FDA COVID-19 Diagnostic Test Fellowship | 9/30/2020 |
| NIH, NIAAA, NIDDK, NIGMS, NIMHD, NLM, NINR, OBSSR, NIDCR, NIDA | Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional) | 9/30/2020 |
| NIH, NIAAA, NIA, NCCIH, NIDCD, NIDDK, NIEHS, NIGMS, NICHD, NIMHD, NLM, NINR, NCATS, OBSSR, NHLBI, NIDCR, NIDA | Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed) | 9/30/2020 |
| NIH, RMOD | NIH Directors Emergency Transformative Research Awards (R01 Clinical Trial Optional) | 9/30/2020 |
| NIH, FIC, NCATS, NHLBI, NIAID, NIAMS, NICHD, NIDA, NIMHD | Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional) | 9/30/2020 |
| NIH, NHLBI | Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials | 10/05/2020 |
| NIH | Notice of Special Interest (NOSI): Availability of Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19) | 10/06/2020 |
| Fundación MAPFRE | 2020 Research Grants in Health Promotion | 10/30/2020 |
| WorkSafeBC | Applied Research to Address The Coronavirus (COVID-19) Emerging Public Health Emergency | 10/31/2020 |
| Biomedical Advanced Research and Development Authority (BARDA) | Applied Research to Address The Coronavirus (COVID-19) Emerging Public Health Emergency | 10/31/2020 |
| NIH – NIA | NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) | 10/01/2020, 11/02/2020, 12/01/2020, 01/04/2021, 02/01/2021 |
| Adira Foundation | Adira's Fast-Track Grant Response: COVID-19
(Alzheimer’s, ALS, Huntington’s, multiple sclerosis, and Parkinson’s) | Continuous |
| Biomedical Advanced Research and Development Authority (BARDA) | BARDA's Division of Research, Innovation & Ventures (DRIVe) Easy Broad Agency Announcement | Continuous |
| Biomedical Advanced Research and Development Authority (BARDA) | Broad Agency Announcement (BAA) - includes COVID-19 areas of interest | Applications accepted on a rolling basis
Deadline: 10/31/2020 |
| Bloomberg Philanthropies | Coronavirus Local Response Initiative | Continuous |
| Cisco | Pandemic/COVID19 Science, Technology and Social Impact | Rolling |
| Department of Energy (DOE) | Department of Energy (DOE) Invitation for COVID-19 scientific questions: | Responses will be reviewed beginning 03/18/2020 |
| Department of Defense (DoD) | Request for Information for PPE in response to COVID-19 | Responses will be reviewed beginning 03/24/2020 |
| Defense Logistics Agency | Request for White Papers: COVID-19 Prototype PPE and Decontamination Equipment | Rolling |
| Gilead Sciences, Inc./ Gilean Sciences Pty Ltd | Investigator Sponsored Research (ISR) | Continuous |
| Google | COVID-19 Related Research credits available from Google Cloud
Research involving the use of patient data, including de-identified data, cannot be considered for this opportunity. Please inform BSD Information Security of your use of Google Cloud resources by emailing: security@bsd.uchicago.edu | |
| International AIDS Society | CIPHER Grant Program | Applications open 10/01/2020 |
| Kaggle | COVID-19 Open Research Dataset Challenge (CORD-19) | Open |
| Merck KGaA | Research Grant for Pandemic Preparedness | Rolling |
| National Science Foundation (NSF) | Rapid Response Research (RAPID) Funding Mechanism
| |
| National Science Foundation (NSF) | Dear Colleague Letter: Provisioning Advanced Cyberinfrastructure to Further Research on the Coronavirus Disease 2019 (COVID-19) | Rapid Proposals; Check with program officers |
| National Science Foundation (NSF) | NSF Rapid Release Funding Mechanism | Rolling |
| NIH | Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) | LOI due 10/05/2020 |
| NIH | Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus | Open through 04/16/2021 |
| NIH | Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities | Open through 05/01/2021 |
| NIH | Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Basic Experimental Studies with Humans Required) | 03/17/2021 |
| NIH | Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Clinical Trials Not Allowed) | 03/17/2021 |
| NIH | Notice of Special Interest: Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA | Open through 04/16/2021 |
| NIH | Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement – Clinical Trial Optional) | See Emergency Notice of Special Interest by IC |
| NIH - NIDCD | Notice of Special Interest (NOSI): NIDCD is Interested in Supporting Research on the Impact of COVID-19 on Mission Specific Sensory and Communication Disorders | 09/08/2022 |
| NIH - NIGMS | Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2
| 2/6/2021 |
| NIH - NCATS | Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need | multiple deadlines; see opportunity |
| NIH - NCATS | Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) | 10/17/2020 |
| NIH - NCATS | Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions and Administrative Supplements to Clinical and Translational Science Award (CTSA) Program Awards to Address 2019 Novel Coronavirus Disease (COVID-19) Public Health Needs | 11/11/2020 |
| NIH - NCATS | Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus and the Behavioral and Social Sciences | Open through 04/01/2021 |
| NIH - NCATS | Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus | Open through 01/26/2022 |
| NIH - NIA and NIMH | Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) | 05/01/2021 |
| NIH - NIAID and NIA | Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required) | 01/13/2021, 05/13/2021, 09/13/2021, 01/13/2022, 05/13/2022 |
| NIH - NIAID | NIAID’s Multi-Pronged Response to the COVID-2019 Outbreak
| 02/06/2021 |
| NIH - NIEHS | Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) | 05/04/2021
|
| NIH - NIBIB | Notice of Special Interest (NOSI): Availability of Emergency Competitive Revision and Administrative Supplements on Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) | Open through 11/10/2020 |
| NIH - NIBIB | Notice of Special Interest (NOSI): Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19) | 03/31/2021 |
| NIH - NINDS, NIAAA | Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System | Open Through 04/15/2021 |
| NIH - NIDCR | Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR | 11/02/2020 |
| NIH - NCATS | Notice of Special Interest (NOSI): New Administrative Supplement Applications to UL1 and U24 CTSA Awards to Address COVID-19 Public Heath Need | 11/11/2020 |
| Novartis | Novartis US COVID-19 Initiative | Continuous |
| PCORI | Phased Large Awards for Comparative Effectiveness Research – Cycle 3 2020 | LOI due 09/29/2020; 01/12/2021 |
| Robert Wood Johnson Foundation | Pioneering Ideas: Exploring the Future to Build a Culture of Health | Continuous |
| The COVID-19 High Performance Computing (HPC) Consortium | The COVID-19 High Performance Computing Consortium | Continuous |
| UK-RAS Network | Medical Robotics for Contagious Diseases Challenge 2020 | 09/30/2020 |
| US Army | Army Applications Lab: Call for COVID-19 Proposals | Continuous |
| NIH, NIMHD, NCI, NIDA, NLM, ODP, OBSSR, NIMH, NIAMS | Notice of Special Interest (NOSI): Simulation Modeling and Systems Science to Address Health Disparities | Continuous |
| NIH, NIAID | Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) | Continuous |
| NIH, NIAD | Notice of Special Interest (NOSI): Availability of Emergency Awards for Limited Clinical Trials to Evaluate Therapeutic and Vaccine Candidates Against SARS-CoV-2 | Continuous |
| NIH, NCATS | Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need | Various
Expires July 10, 2021 |
| NIH, NCATS | Notice of Special Interest (NOSI): Repurposing Existing Therapeutics to Address the 2019 Novel Coronavirus Disease (COVID-19) | 10/5/2020;
10/16/2020 |
| NIH, NCATS, NCCIH, NCI, NHGRI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDCD, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINR, NLM, ORWH, OSC | Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) | Various |
| NIH, NCI, NHGRI, NCCIH, NINDS, ORIP, NIMHD, NIA, NIDCR, NIAID, NIAMS, NIEHS, NCATS, NIDCD, NICHD, NIDDK, NHLBI | Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project | 7/12/2021 |
| NIH, NIAID | Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) | 7/01/2021 |
| Department of State | COVID-19 Private Sector Engagement & Partnership Fund | 5/28/2021 |
| NIH, NIDA | Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus | 3/31/2021 |
| NIMH, NCCIH, SGMRO, ODP, NIDCD, OBSSR, NEI, NIDA, NIA, NIAAA, NICHD, NCATS, ORWH, NIDCR, NINR, NIMHD | Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) | 3/02/2021 |
| NIH, NCATS | Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements for Tissue Chips Research on the 2019 Novel Coronavirus | 1/25/2021 |
| NIH, NCATS | Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required) | 1/23/2021 |
| HHS | Annual Estimates of Influenza Vaccine Effectiveness for Preventing Medically Attended Laboratory-Confirmed Influenza in the United States | 01/08/2021 |
| NIH, NIMHD, NIAAA, NCCIH, NIDCR, NCATS, NIEHS, ORWH, NIDA, OBSSR, NIDCD, SGMRO, NICHD, ODP, NIMH, NHLBI, NIA, NEI, NIDDK | Notice of Special Interest (NOSI): Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations | 12/29/2020 |
| NIH, NIDDK | Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional) | 12/16/2020 |
| NIMHD, NIDCD, NIMH, ODP, NINR, NIA, SGMRO, NIDDK, NIEHS, NICHD, NCATS, ORWH, NIAAA, NCCIH, NIDA, NEI, NIDCR | Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) | 12/01/2020 |
| Russell Sage Foundation | Social, Political, Economic, and Psychological Consequences of the COVID-19 Pandemic | 11/04/2020; 11/11/2020 |
